Buy Biotech When There's Blood On The Street: Pontifax's Ran Nussbaum
September 07, 2015 at 09:00 AM EDT
Ran Nussbaum, managing partner with The Pontifax Group, doesn't worry too much about overall market volatility. Biotechs, he feels, are somewhat immune to turmoil because their fundamentals are based in real life.